Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Therapy crawled time : 04:20 save search
CARVYKTI® is the First and Only BCMA-Targeted Treatment Approved by the U.S. FDA for Patients with Relapsed or Refractory Multiple Myeloma Who Have Received at Least One Prior Line of Therapy
Published: 2024-04-06 (Crawled : 04:20) - prnewswire.com
JNJ | News | $144.77 0.22% 0.4% 130K
|
Health Technology
| Email alert
Add to watchlist
carvykti fda first approved one treatment for therapy
Therapy Co. SPAC Investors Fight Del. Stock-Drop Suit Toss – Law360
Published: 2023-12-02 (Crawled : 04:20) - spacfeed.com
APXI 4 | $11.45 0.09% -0.09% 0
|
n/a
| Email alert
Add to watchlist
spac therapy
Global Oxygen Concentrators Industry Report 2023: A $5.1 Billion Market by 2030 - IoT Integration and Rising Preference for Home-Based Oxygen Therapy to Propel Growth
Published: 2023-08-12 (Crawled : 04:20) - prnewswire.com
IVC | $0.6598 -19.67% 0
|
Health Technology
| Email alert
Add to watchlist
INGN | $6.95 0.29% 0.29% 0
|
Health Technology
| Email alert
Add to watchlist
PHG | News | $20.15 -0.89% -0.6% 960
|
Health Technology
| Email alert
Add to watchlist
IVCRQ | $0.0135 25.93% 110K
|
n/a
| Email alert
Add to watchlist
propel integration report iot global oxygen therapy growth market
Breast Cancer Therapeutics Market Research Report 2023: Therapy, Chemotherapy Drugs, Hormone Therapy, Targeted Therapy - Global Forecasts to 2027
Published: 2023-03-04 (Crawled : 04:20) - prnewswire.com
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
NVS | News | $93.08 -0.13% -0.04% 670
|
Health Technology
| Email alert
Add to watchlist
AZN | $68.53 0.39% 0.39% 4.3K
|
Health Technology
| Email alert
Add to watchlist
BMY | $47.84 -0.87% 0.48% 9.9M
|
Health Technology
| Email alert
Add to watchlist
AZNCF | $140.15 3.58% -4.19% 560
|
Health Technology
| Email alert
Add to watchlist
research global report breast therapeutics therapy cancer market hormone
ATI Physical Therapy INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of ATI Physical Therapy, Inc. f/k/a Fortress Value Acquisition Corp. II - ATIP
Published: 2022-05-14 (Crawled : 04:20) - prnewswire.com
ATIP 4 | $4.17 -2.81% 0.0% 0
|
Manufacturing
| Email alert
Add to watchlist
acquisition therapy
Cancer Therapies Market size in Europe to Grow by USD 34.71 billion | Technavio
Published: 2022-04-02 (Crawled : 04:20) - prnewswire.com
AMGN | $264.07 -0.59% -0.59% 350
|
Health Technology
| Email alert
Add to watchlist
AZN | $68.53 0.39% 0.39% 4.3K
|
Health Technology
| Email alert
Add to watchlist
GSK | $39.6 -0.88% -0.05% 8.7K
|
Health Technology
| Email alert
Add to watchlist
NVS | News | $93.08 -0.13% -0.04% 670
|
Health Technology
| Email alert
Add to watchlist
GLAXF | $20.2 0.65% -14.18% 0
|
Health Technology
| Email alert
Add to watchlist
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
AZNCF | $140.15 3.58% -4.19% 560
|
Health Technology
| Email alert
Add to watchlist
europe cancer market therapy
Pomerantz Law Firm Announces the Filing of a Class Action Against ATI Physical Therapy, Inc. f/k/a Fortress Value Acquisition Corp. II and Certain Officers and Directors - ATIP; FVAC
Published: 2021-08-21 (Crawled : 04:20) - prnewswire.com
ATIP 4 | $4.17 -2.81% 0.0% 0
|
Manufacturing
| Email alert
Add to watchlist
acquisition therapy acquisition corp
Gainers vs Losers
| 42% | 58% |
Top 10 Gainers
UAL | News | $49.705 1.98% 1.7M
|
Transportation
TTEC M | $7.975 1.08% 17
|
Commercial Services
TWO 4 | $11.83 0.42% 13K
|
Finance
TTC 4 | $84.585 0.36% 2.9K
|
Producer Manufacturing
UBER A | $72.19 0.35% 160K
|
Technology Services
UAA | $6.565 0.23% 32K
|
Consumer Non-Durables
TTD 4 | $80.31 0.22% 22K
|
Commercial Services
TWLO | $58.72 -0.03% 24K
|
Technology Services
UBS | $28.08 -0.11% 97K
|
Finance
U | $23.57 -0.63% 130K
|
Technology Services
Your saved searches
Save your searches and get alerts when important news are released.